Pursuant to Regulation 30 read with Para A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), Kabra Drugs has enclosed proceedings of the Extra Ordinary General Meeting of the Company held on Thursday, January 02, 2025 at 11.00 AM at the registered office of the Company.
The above information is a part of company’s filings submitted to BSE.